AMPH FY 2018 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$295M+22.7% YoY

Gross Profit

$107M36.3% margin

Operating Income

-$9M-2.9% margin

Net Income

-$6M-1.9% margin

EPS (Diluted)

$-0.12

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

-$9M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$514M

Total Liabilities

$149M

Stockholders' Equity

$332M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$295M	$240M	+22.7%
Gross Profit	$107M	$91M	+17.8%
Operating Income	-$9M	-$895,000	-863.5%
Net Income	-$6M	$5M	-227.3%